TRAD CHI MED (0570.HK)
- Previous Close
2.130 - Open
2.130 - Bid 2.150 x --
- Ask 2.160 x --
- Day's Range
2.130 - 2.170 - 52 Week Range
1.780 - 4.460 - Volume
13,400,300 - Avg. Volume
37,599,743 - Market Cap (intraday)
10.827B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
215.00 - EPS (TTM)
0.010 - Earnings Date Mar 25, 2025
- Forward Dividend & Yield 0.00 (0.16%)
- Ex-Dividend Date Jun 23, 2025
- 1y Target Est
1.70
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It operates through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. The company manufactures, manages, and sells concentrated TCM granules, and TCM health care products and decoction pieces, as well as TCM finished drugs. It also provides Chinese medical related healthcare solutions, including Chinese medical consultation and diagnosis, TCM physiotherapy, and prescription with concentrated TCM granules, TCM decoction pieces, and TCM healthcare product through its offline medical institutions. In addition, the company is involved in the retail sale of pharmaceuticals and decoction pharmaceutical; trading of pharmaceutical product; investment of the TCM health industry; sale of medical herb; provision of marketing, advertising and consulting of TCM; and property leasing activities. It sells its products under the Yi Fang, Tian Jiang, Tong Ji Tang, Medi-world, De Zhong, and Feng Liao Xing brands through hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in 2016. China Traditional Chinese Medicine Holdings Co. Limited was founded in 1955 and is based in Wan Chai, Hong Kong.
www.china-tcm.com.cn16,753
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 0570.HK
View MorePerformance Overview: 0570.HK
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0570.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0570.HK
View MoreValuation Measures
Market Cap
10.73B
Enterprise Value
9.30B
Trailing P/E
183.84
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.60
Price/Book (mrq)
0.47
Enterprise Value/Revenue
0.52
Enterprise Value/EBITDA
5.61
Financial Highlights
Profitability and Income Statement
Profit Margin
0.33%
Return on Assets (ttm)
1.30%
Return on Equity (ttm)
0.09%
Revenue (ttm)
16.51B
Net Income Avi to Common (ttm)
54.07M
Diluted EPS (ttm)
0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
5.27B
Total Debt/Equity (mrq)
16.78%
Levered Free Cash Flow (ttm)
2.84B